{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:41:47Z","timestamp":1768387307370,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a strong association between type 2 diabetes mellitus (T2DM) and rectal cancer (RC), but a detailed understanding of the potential mechanistic links and gene regulatory interactions between these two diseases remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The differential expression analysis and RT-qPCR were performed on the expression data of T2DM and RC to identify shared differentially expressed genes (DEGs) between these diseases. Functional enrichment and protein\u2013protein interaction (PPI) analyses were conducted. Subsequently, the Cytoscape software was used to calculate the protein centrality PPI network diagram and screen hub genes. Predictive analyses were performed for upstream transcription factors (TFs) of these hub genes to uncover potential regulatory mechanisms. Additionally, candidate TFs were analyzed for modulation of upstream drugs, including molecular docking studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression data analysis of T2DM and RC identified 17 significantly upregulated and 111 significantly downregulated genes in both diseases. Further PPI analysis and centrality calculation highlighted 15 genes, including SYP, as central within the interaction network, suggesting their key regulatory roles in T2DM and RC. In addition, we used RT-PCR to detect the expression of several DEG genes in T2DM and RC, and the results showed that CDH3, CHGA, ESR1, SCG3, SP1 and SYP genes were the highest in patients with comorbidities, while compared with normal healthy people, the expression of CDH3, CHGA, ESR1, SCG3, SP1 and SYP genes was higher. The expressions of CDH3, CHGA, ESR1, SCG3, SP1 and SYP genes were also significantly increased in T2DM and RC, which was consistent with our prediction. Transcription factor prediction indicated that SP1 could regulate multiple hub genes, suggesting its pivotal regulatory role in T2DM and RC. Further molecular docking revealed that SP1 may target genes for stearic acid and (\u2212)-epigallocatechin-3-gallate (EGCG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Genes such as SYP show significant differential expression in both T2DM and RC and may play significant roles in the progression of T2DM and RC. Transcription factor analysis suggested that SP1 could regulate multiple hub genes. Molecular docking indicated that SP1 is a potential target for active components like stearic acid and EGCG in\n                      <jats:italic>Ginkgo biloba<\/jats:italic>\n                      , highlighting its potential as a therapeutic agent for T2DM and RC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03640-x","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T19:06:22Z","timestamp":1765393582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening and predictive analysis of common regulatory genes in diabetes and rectal cancer: transcriptional and drug modulation mechanisms"],"prefix":"10.1186","volume":"31","author":[{"given":"Shuxing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyi","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"3640_CR1","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015. 385 9963 117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"issue":"1","key":"3640_CR2","doi-asserted-by":"publisher","first-page":"2570212","DOI":"10.1080\/10641963.2025.2570212","volume":"47","author":"J Wu","year":"2025","unstructured":"Wu J, et al. Interdisciplinary collaborative care model combined with family empowerment in patients with comorbid hypertension and diabetes: a study on blood pressure\/glucose control and psychosocial adaptation based on the COM-B model. Clin Exp Hypertens. 2025;47(1):2570212.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"3640_CR3","doi-asserted-by":"publisher","first-page":"2564299","DOI":"10.1080\/10641963.2025.2564299","volume":"47","author":"F Guo","year":"2025","unstructured":"Guo F, et al. Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes. Clin Exp Hypertens. 2025;47(1):2564299.","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"3640_CR4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1677\/ERC-09-0087","volume":"16","author":"P Vigneri","year":"2009","unstructured":"Vigneri P, et al. Diabetes and cancer. Endocr Relat Cancer. 2009;16(4):1103\u201323.","journal-title":"Endocr Relat Cancer"},{"issue":"12","key":"3640_CR5","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1002\/1097-0142(19841215)54:12<3070::AID-CNCR2820541243>3.0.CO;2-N","volume":"54","author":"JC Williams","year":"1984","unstructured":"Williams JC, Walsh DA, Jackson JF. Colon carcinoma and diabetes mellitus. Cancer. 1984;54(12):3070\u20131.","journal-title":"Cancer"},{"issue":"2","key":"3640_CR6","first-page":"164","volume":"6","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995;6(2):164\u201379.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"3640_CR7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1053\/j.gastro.2004.07.011","volume":"127","author":"Y-X Yang","year":"2004","unstructured":"Yang Y-X, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 2004;127(4):1044\u201350.","journal-title":"Gastroenterology"},{"issue":"6","key":"3640_CR8","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","volume":"132","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132(6):2208\u201325.","journal-title":"Gastroenterology"},{"issue":"5","key":"3640_CR9","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1530\/ERC-11-0374","volume":"19","author":"DH Cohen","year":"2012","unstructured":"Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012;19(5):F27\u201345.","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"3640_CR10","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","volume":"57","author":"L Deng","year":"2012","unstructured":"Deng L, et al. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci. 2012;57(6):1576\u201385.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"3640_CR11","first-page":"967","volume":"23","author":"AA Onitilo","year":"2012","unstructured":"Onitilo AA, et al. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control. 2012;23(6):967\u201381.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"3640_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00125-003-1109-5","volume":"46","author":"CK Chang","year":"2003","unstructured":"Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia. 2003;46(5):595\u2013607.","journal-title":"Diabetologia"},{"issue":"1","key":"3640_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clinre.2015.05.021","volume":"40","author":"S Luo","year":"2016","unstructured":"Luo S, et al. Diabetes mellitus increases the risk of colorectal neoplasia: an updated meta-analysis. Clin Res Hepatol Gastroenterol. 2016;40(1):110\u201323.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"11","key":"3640_CR14","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/j.1463-1318.2012.02875.x","volume":"14","author":"W Luo","year":"2012","unstructured":"Luo W, et al. Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies. Colorectal Dis. 2012;14(11):1307\u201312.","journal-title":"Colorectal Dis"},{"issue":"2","key":"3640_CR15","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3892\/ol.2020.11707","volume":"20","author":"S Liu","year":"2020","unstructured":"Liu S, et al. Mechanism of miR-98 inhibiting tumor proliferation and invasion by targeting IGF1R in diabetic patients combined with colon cancer. Oncol Lett. 2020;20(2):1719\u201326.","journal-title":"Oncol Lett"},{"issue":"1","key":"3640_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12964-023-01193-2","volume":"21","author":"Q Wu","year":"2023","unstructured":"Wu Q, et al. PECAM-1 drives \u03b2-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus. Cell Commun Signal. 2023;21(1):203.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"3640_CR17","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.","journal-title":"Innovation"},{"issue":"5","key":"3640_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"3640_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3640_CR20","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457\u201362.","journal-title":"Nucleic Acids Res"},{"key":"3640_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"key":"3640_CR22","doi-asserted-by":"crossref","unstructured":"Chin, C.-H., et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Systems Biology. 2014. 8 Suppl 4(Suppl 4): p. S11.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"issue":"10","key":"3640_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00723-022-01478-8","volume":"53","author":"G Angles","year":"2022","unstructured":"Angles G, et al. Atomistic simulations modify interpretation of spin-label oximetry data. part 1: intensified water-lipid interfacial resistances. Appl Magn Reson. 2022;53(10):1431\u20133.","journal-title":"Appl Magn Reson"},{"issue":"D1","key":"3640_CR24","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46(D1):D380\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3640_CR25","doi-asserted-by":"publisher","first-page":"2326021","DOI":"10.1080\/10641963.2024.2326021","volume":"46","author":"W Zhang","year":"2024","unstructured":"Zhang W, et al. Chicoric acid advanced PAQR3 ubiquitination to ameliorate ferroptosis in diabetes nephropathy through the relieving of the interaction between PAQR3 and P110\u03b1 pathway. Clin Exp Hypertens. 2024;46(1):2326021.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"3640_CR26","doi-asserted-by":"publisher","first-page":"2402260","DOI":"10.1080\/10641963.2024.2402260","volume":"46","author":"L Yang","year":"2024","unstructured":"Yang L, et al. Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring. Clin Exp Hypertens. 2024;46(1):2402260.","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"3640_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31083\/j.rcm2402033","volume":"24","author":"Y Ji","year":"2023","unstructured":"Ji Y, et al. The value of RBP4 in assessing coronary artery elasticity in patients with coronary heart disease and type 2 diabetes mellitus. Rev Cardiovasc Med. 2023;24(2):33.","journal-title":"Rev Cardiovasc Med"},{"issue":"6","key":"3640_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31083\/j.rcm2506207","volume":"25","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Positive correlation between BMI and left ventricle and atrium inside diameter size in Chinese type 2 diabetes patients with left ventricular and atrial enlargement. Rev Cardiovasc Med. 2024;25(6):207.","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"3640_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.31083\/j.rcm2507263","volume":"25","author":"E Nyl\u00e9n","year":"2024","unstructured":"Nyl\u00e9n E. Age, race, sex and cardiorespiratory fitness: implications for prevention and management of cardiometabolic disease in individuals with diabetes mellitus. Rev Cardiovasc Med. 2024;25(7):263.","journal-title":"Rev Cardiovasc Med"},{"issue":"3","key":"3640_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4239\/wjd.v5.i3.372","volume":"5","author":"C-X Xu","year":"2014","unstructured":"Xu C-X, Zhu H-H, Zhu Y-M. Diabetes and cancer: associations, mechanisms, and implications for medical practice. World J Diabetes. 2014;5(3):372\u201380.","journal-title":"World J Diabetes"},{"issue":"4","key":"3640_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/sj.bjc.6604917","volume":"100","author":"KY Wolin","year":"2009","unstructured":"Wolin KY, et al. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009;100(4):611\u20136.","journal-title":"Br J Cancer"},{"issue":"20","key":"3640_CR32","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/jnci\/djs354","volume":"104","author":"T Boyle","year":"2012","unstructured":"Boyle T, et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(20):1548\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"3640_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/dmrr.2488","volume":"30","author":"S Mann","year":"2014","unstructured":"Mann S, et al. Changes in insulin sensitivity in response to different modalities of exercise: a review of the evidence. Diabetes Metab Res Rev. 2014;30(4):257\u201368.","journal-title":"Diabetes Metab Res Rev"},{"key":"3640_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7249","volume":"342","author":"T Dwyer","year":"2011","unstructured":"Dwyer T, et al. Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study. BMJ. 2011;342:c7249.","journal-title":"BMJ"},{"issue":"1","key":"3640_CR35","doi-asserted-by":"publisher","first-page":"2373467","DOI":"10.1080\/10641963.2024.2373467","volume":"46","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Inhibition of Th17 cell differentiation by aerobic exercise improves vasodilatation in diabetic mice. Clin Exp Hypertens. 2024;46(1):2373467.","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"3640_CR36","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1017\/S0029665110001928","volume":"69","author":"J W\u00e4rnberg","year":"2010","unstructured":"W\u00e4rnberg J, et al. Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc. 2010;69(3):400\u20136.","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"3640_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1249\/00005768-199402000-00003","volume":"26","author":"BK Pedersen","year":"1994","unstructured":"Pedersen BK, Ullum H. NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc. 1994;26(2):140\u20136.","journal-title":"Med Sci Sports Exerc"},{"issue":"1\u20132","key":"3640_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jsbmb.2005.06.018","volume":"97","author":"ED Gorham","year":"2005","unstructured":"Gorham ED, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol. 2005;97(1\u20132):179\u201394.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"3640_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5056\/jnm.2012.18.1.64","volume":"18","author":"BK Song","year":"2012","unstructured":"Song BK, et al. Colon transit time according to physical activity level in adults. J Neurogastroenterol Motil. 2012;18(1):64\u20139.","journal-title":"J Neurogastroenterol Motil"},{"key":"3640_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2017.08.039","author":"IL Leeds","year":"2017","unstructured":"Leeds IL, et al. The independent effect of cancer on outcomes: a potential limitation of surgical risk prediction. J Surg Res. 2017. https:\/\/doi.org\/10.1016\/j.jss.2017.08.039.","journal-title":"J Surg Res"},{"key":"3640_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/CLEP.S229935","volume":"12","author":"MA Luque-Fernandez","year":"2020","unstructured":"Luque-Fernandez MA, et al. Multimorbidity by patient and tumor factors and time-to-surgery among colorectal cancer patients in Spain: a population-based study. Clin Epidemiol. 2020;12:31\u201340.","journal-title":"Clin Epidemiol"},{"key":"3640_CR42","doi-asserted-by":"publisher","first-page":"6072438","DOI":"10.1155\/2023\/6072438","volume":"2023","author":"L Huang","year":"2023","unstructured":"Huang L, et al. Bioinformatics analysis of the inflammation-associated lncRNA-mRNA coexpression network in type 2 diabetes. J Renin Angiotensin Aldosterone Syst. 2023;2023:6072438.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"4","key":"3640_CR43","first-page":"371","volume":"11","author":"JRB Perry","year":"2008","unstructured":"Perry JRB, Frayling TM. New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care. 2008;11(4):371\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"3640_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41598-020-57599-2","volume":"10","author":"FC Ning","year":"2020","unstructured":"Ning FC, et al. VEGF-B ablation in pancreatic \u03b2-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake. Sci Rep. 2020;10(1):923.","journal-title":"Sci Rep"},{"issue":"3","key":"3640_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.11613\/BM.2013.033","volume":"23","author":"S Cernea","year":"2013","unstructured":"Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem Med. 2013;23(3):266\u201380.","journal-title":"Biochem Med"},{"issue":"1","key":"3640_CR46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, et al. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.","journal-title":"Mol Cancer"},{"issue":"3","key":"3640_CR47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.21037\/jgo-23-120","volume":"14","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, et al. Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer. J Gastrointest Oncol. 2023;14(3):1307\u201319.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"3640_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","volume":"14","author":"H Yadav","year":"2011","unstructured":"Yadav H, et al. Protection from obesity and diabetes by blockade of TGF-\u03b2\/Smad3 signaling. Cell Metab. 2011;14(1):67\u201379.","journal-title":"Cell Metab"},{"issue":"17","key":"3640_CR49","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.7150\/thno.77043","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-\u03b2 signaling. Theranostics. 2022;12(17):7250\u201366.","journal-title":"Theranostics"},{"issue":"24","key":"3640_CR50","doi-asserted-by":"publisher","first-page":"35643","DOI":"10.1007\/s11356-022-19499-y","volume":"29","author":"T Behl","year":"2022","unstructured":"Behl T, et al. Exploring the multifaceted role of TGF-\u03b2 signaling in diabetic complications. Environ Sci Pollut Res Int. 2022;29(24):35643\u201356.","journal-title":"Environ Sci Pollut Res Int"},{"key":"3640_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043665","author":"A Kasprzak","year":"2023","unstructured":"Kasprzak A. Autophagy and the insulin-like growth factor (IGF) system in colonic cells: implications for colorectal neoplasia. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24043665.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3640_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28121","volume":"10","author":"S Jang","year":"2024","unstructured":"Jang S, et al. Sex differences in inflammation correlated with estrogen and estrogen receptor-\u03b2 levels in azoxymethane\/dextran sodium sulfate-induced colitis-associated colorectal cancer mice. Heliyon. 2024;10(6):e28121.","journal-title":"Heliyon"},{"issue":"12","key":"3640_CR53","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1158\/1055-9965.EPI-05-0514","volume":"14","author":"ML Slattery","year":"2005","unstructured":"Slattery ML, et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2936\u201342.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"3640_CR54","first-page":"521","volume":"54","author":"J\u00c1 Cahua-Pablo","year":"2016","unstructured":"Cahua-Pablo J\u00c1, Flores-Alfaro E, Cruz M. Estrogen receptor alpha in obesity and diabetes. Rev Med Inst Mex Seguro Soc. 2016;54(4):521\u201330.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"issue":"7","key":"3640_CR55","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2174\/1573399815666190718144722","volume":"16","author":"DN Toaima","year":"2020","unstructured":"Toaima DN, et al. Effect of estrogen receptor- alpha gene polymorphism (IVS1-397 T>C) on microvascular complications of type 1 diabetes mellitus. Curr Diabetes Rev. 2020;16(7):770\u20138.","journal-title":"Curr Diabetes Rev"},{"issue":"11","key":"3640_CR56","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2217\/bmm-2016-0091","volume":"10","author":"K Broedbaek","year":"2016","unstructured":"Broedbaek K, Hilsted L. Chromogranin A as biomarker in diabetes. Biomark Med. 2016;10(11):1181\u20139.","journal-title":"Biomark Med"},{"issue":"1","key":"3640_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12882-022-02667-0","volume":"23","author":"H Yu","year":"2022","unstructured":"Yu H, et al. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. BMC Nephrol. 2022;23(1):41.","journal-title":"BMC Nephrol"},{"key":"3640_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.archoralbio.2015.11.005","volume":"62","author":"EM Kogawa","year":"2016","unstructured":"Kogawa EM, et al. Impact of glycemic control on oral health status in type 2 diabetes individuals and its association with salivary and plasma levels of chromogranin A. Arch Oral Biol. 2016;62:10\u20139.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"3640_CR59","first-page":"2","volume":"10","author":"M Soell","year":"2010","unstructured":"Soell M, et al. Chromogranin A detection in saliva of type 2 diabetes patients. Bosn J Basic Med Sci. 2010;10(1):2\u20138.","journal-title":"Bosn J Basic Med Sci"},{"issue":"1","key":"3640_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/nyas.14249","volume":"1455","author":"SK Mahata","year":"2019","unstructured":"Mahata SK, Corti A. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation. Ann N Y Acad Sci. 2019;1455(1):34\u201358.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3640_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00345-022-04248-0","volume":"41","author":"G Ploussard","year":"2023","unstructured":"Ploussard G, et al. Chromogranin A: a useful biomarker in castration-resistant prostate cancer. World J Urol. 2023;41(2):361\u20139.","journal-title":"World J Urol"},{"issue":"6","key":"3640_CR62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4103\/aja.aja_57_18","volume":"20","author":"P Hong","year":"2018","unstructured":"Hong P, et al. Prognostic role of chromogranin A in castration-resistant prostate cancer: a meta-analysis. Asian J Androl. 2018;20(6):561\u20136.","journal-title":"Asian J Androl"},{"issue":"11","key":"3640_CR63","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/PAS.0000000000001526","volume":"44","author":"J Kim","year":"2020","unstructured":"Kim J, et al. Chromogranin A expression in rectal neuroendocrine tumors is associated with more aggressive clinical behavior and a poorer prognosis. Am J Surg Pathol. 2020;44(11):1496\u2013505.","journal-title":"Am J Surg Pathol"},{"key":"3640_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","volume":"152","author":"C Vizca\u00edno","year":"2015","unstructured":"Vizca\u00edno C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111\u201324.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"3640_CR65","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/157340611796799203","volume":"7","author":"UT Sankpal","year":"2011","unstructured":"Sankpal UT, et al. Targeting Sp1 transcription factors in prostate cancer therapy. Med Chem. 2011;7(5):518\u201325.","journal-title":"Med Chem"},{"issue":"1","key":"3640_CR66","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12967-023-04141-3","volume":"21","author":"X Xu","year":"2023","unstructured":"Xu X, et al. Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer. J Transl Med. 2023;21(1):307.","journal-title":"J Transl Med"},{"issue":"1","key":"3640_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, et al. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression. Mol Cancer. 2022;21(1):77.","journal-title":"Mol Cancer"},{"key":"3640_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031153","author":"B Vellingiri","year":"2020","unstructured":"Vellingiri B, et al. Understanding the role of the transcription factor Sp1 in ovarian cancer: from theory to practice. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21031153.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3640_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12253-014-9880-9","volume":"21","author":"G Chen","year":"2015","unstructured":"Chen G, et al. Identification of key genes associated with colorectal cancer based on the transcriptional network. Pathol Oncol Res. 2015;21(3):719\u201325.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"3640_CR70","doi-asserted-by":"publisher","first-page":"9928","DOI":"10.1080\/21655979.2022.2062196","volume":"13","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Sp1 transcription factor represses transcription of phosphatase and tensin homolog to aggravate lung injury in mice with type 2 diabetes mellitus-pulmonary tuberculosis. Bioengineered. 2022;13(4):9928\u201344.","journal-title":"Bioengineered"},{"key":"3640_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154334","volume":"111","author":"X Liu","year":"2020","unstructured":"Liu X, et al. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway. Metabolism. 2020;111:154334.","journal-title":"Metabolism"},{"key":"3640_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155340","volume":"138","author":"Y Hui","year":"2023","unstructured":"Hui Y, et al. Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R\/PKA\/SP1\/ERp29\/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization. Metabolism. 2023;138:155340.","journal-title":"Metabolism"},{"key":"3640_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"issue":"246","key":"3640_CR74","first-page":"255","volume":"35","author":"R Tabrizi","year":"2020","unstructured":"Tabrizi R, et al. Effects of Ginkgo biloba intake on cardiometabolic parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of clinical trials. Phytother Res. 2020;35(246):255.","journal-title":"Phytother Res"},{"key":"3640_CR75","doi-asserted-by":"publisher","first-page":"1231053","DOI":"10.3389\/fendo.2023.1231053","volume":"14","author":"H Zou","year":"2023","unstructured":"Zou H, et al. Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1231053.","journal-title":"Front Endocrinol"},{"issue":"6","key":"3640_CR76","doi-asserted-by":"publisher","DOI":"10.2174\/0115701638282497240124102345","volume":"21","author":"S Hamdani","year":"2024","unstructured":"Hamdani S, Allali H, Bouchentouf S. Exploring the therapeutic potential of Ginkgo biloba polyphenols in targeting biomarkers of colorectal cancer: an in-silico evaluation. Curr Drug Discov Technol. 2024;21(6):e020224226651.","journal-title":"Curr Drug Discov Technol"},{"issue":"9","key":"3640_CR77","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037218","volume":"103","author":"M Wang","year":"2024","unstructured":"Wang M, et al. Exploration of Ginkgo biloba leaves on non-small cell lung cancer based on network pharmacology and molecular docking. Medicine. 2024;103(9):e37218.","journal-title":"Medicine"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03640-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:55:53Z","timestamp":1768366553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3640"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03640-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}